Revolutionizing solid tumor treatments: The rise of immuno-oncology innovations in 2024

Revolutionizing solid tumor treatments: The rise of immuno-oncology innovations in 2024

Saved in:

Bibliographic Details
Main Authors:	Gokul Sudhakaran, SathishKumar kuppusamy, Moovendhan Meivelu, Hari Deva Muthu
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024002814
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Revolutionizing healthcare: The transformative power of AI in personalized medicine
by: Kuppusamy Sathishkumar, et al.
Published: (2024-06-01)

Exploring zebrafish xenograft models for human oral cancer research
by: Gokul Sudhakaran, et al.
Published: (2024-06-01)

AI and genomics: Navigating the future of personalized medicine and ethical challenges
by: Kuppusamy Sathishkumar, et al.
Published: (2024-06-01)

Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials
by: B. Haridevamuthu, et al.
Published: (2024-06-01)

Immunodynamics of explanted human tumors for immuno‐oncology
by: Agathe Dubuisson, et al.
Published: (2020-12-01)

Updated liquid biopsy techniques for non-invasive oral cancer detection and monitoring in 2024
by: Gokul Sudhakaran
Published: (2024-06-01)

Adjuvant therapy with immuno-modulators în oncology
by: Ioana Chitescu, et al.
Published: (2019-05-01)

Ten challenges and opportunities in computational immuno-oncology
by: Hong Zhang, et al.
Published: (2024-10-01)

A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells
by: Nazila Bahmaie, et al.
Published: (2024-12-01)

Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine
by: Lucillia Bezu, et al.
Published: (2025-12-01)

Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology
by: Alejandro Serrano, et al.
Published: (2024-11-01)

From Genomics to AI: Revolutionizing Precision Medicine in Oncology
by: Giulia Calvino, et al.
Published: (2025-06-01)

Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology
by: Yifei Ge, et al.
Published: (2024-11-01)

Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology
by: Fabiano Flauto, et al.
Published: (2025-03-01)

Cardiotoxicity of genetic engineered biological therapy in immuno-mediated and oncological diseases
by: V. A. Akhmedov, et al.
Published: (2024-04-01)

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies
by: Meiqi Miao, et al.
Published: (2025-03-01)

Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
by: Carolina Alves Costa Silva, et al.
Published: (2025-03-01)

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01)

Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01)

Letter to editor: Comment on “identification of a potential prognostic panel of biomarkers for stratification of head and neck squamous cell carcinoma based on HPV status and TP53 mutational status”
by: Gokul Sudhakaran
Published: (2024-09-01)

The pivotal role of the microbiome in oral cancer: Recent insights and future directions
by: Gokul Sudhakaran
Published: (2024-06-01)

Intelligence overload: How AI is rewiring our approach to neurodegenerative diseases
by: Gokul Sudhakaran
Published: (2024-01-01)

Revolutionizing oncology care: pioneering AI models to foresee pneumonia-related mortality
by: Qunzhe Ding, et al.
Published: (2025-03-01)

Revolutionizing precision oncology: the role of artificial intelligence in personalized pediatric cancer care
by: Hasan Hashem, et al.
Published: (2025-05-01)

Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools
by: Varun Dewaker, et al.
Published: (2025-03-01)

Revolutionizing oral health care: The promise of terahertz radiation for oral oncological lesions
by: Alice AlSabbag, et al.
Published: (2024-12-01)

Editorial: Immuno-oncologic biomarker signatures for personalized immunotherapy and immunoprevention in oral squamous cell carcinoma
by: Rania H. Younis, et al.
Published: (2025-06-01)

Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
by: Cheol-Kyu Park, MD, PhD, et al.
Published: (2025-03-01)

Machine learning explores the prognostic and immuno-oncological impact of mitochondrial unfolded protein response in CESC
by: Keh-Sen Liu, et al.
Published: (2025-05-01)

Editorial: Rising stars in urologic oncology: 2023
by: Juan Gomez Rivas, et al.
Published: (2025-03-01)

Nanoformulation innovations: Revolutionizing precision in migraine therapy
by: Mohammad Ghasemi Farimani, et al.
Published: (2025-01-01)

Association of circulating immuno-oncology biomarkers with breast cancer risk: insights from two prospective cohorts
by: Jing Zheng, et al.
Published: (2025-07-01)

A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
by: Zihan Quan, et al.
Published: (2025-12-01)

Emerging Concepts in Immuno-Oncology: Insights from Natural Language Processing-Driven Co-Occurrence Analysis
by: Kavita A Iyer, et al.
Published: (2025-06-01)

Immuno-oncologic profiling by stage-dependent transcriptome and proteome analyses of spontaneously regressing canine cutaneous histiocytoma
by: Alina K. Loriani Fard, et al.
Published: (2024-11-01)

Solid-State lithium-ion battery electrolytes: Revolutionizing energy density and safety
by: P.U. Nzereogu, et al.
Published: (2025-03-01)

From lab to lifesaver: the rise of CAR T-cell therapy in oncology
by: Shriyash S. Jangavali, et al.
Published: (2025-05-01)

Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model
by: Yong Wha Moon, et al.
Published: (2020-10-01)

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
by: Malin Hagberg Thulin, et al.
Published: (2025-06-01)

Correction: SITC clinical Immuno-Oncology network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials
Published: (2024-03-01)